TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm

Br J Haematol. 2011 May;153(3):413-6. doi: 10.1111/j.1365-2141.2010.08556.x. Epub 2011 Jan 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • DNA-Binding Proteins / genetics*
  • Dendritic Cells / pathology*
  • Dioxygenases
  • Female
  • Hematologic Neoplasms / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Neoplasm Proteins / genetics
  • Proto-Oncogene Proteins / genetics*
  • Skin Neoplasms / genetics*
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • DNA-Binding Proteins
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Dioxygenases
  • TET2 protein, human